External Publication
Visit Post

STAT+: GSK advancing ovarian cancer drug mo-rez

STAT [Unofficial] April 13, 2026
Source
Revolution Medicines 'unprecedented' cancer trial data, Allogene's off-the-shelf CAR-T, and other biotech news

Discussion in the ATmosphere

Loading comments...